News, Announcements and Expert Commentary from Inova

Posts Tagged ‘genomics’

FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

Prenatal Genetic Tests and Care for High-Risk Obstetric Patients (Video with Dr. Sarah Poggi)

In this video, Inova’s Dr. Sarah Poggi provides information about advances in prenatal testing. This lecture includes information about prenatal single gene deletion carrier testing; non-invasive prenatal testing (NIPT) using cell-free DNA; and microarray analysis. Dr. Poggi is a maternal-fetal medicine specialist at the Brock Family Antenatal Testing Center at Inova Alexandria Hospital in Northern…

Read More

Considering New Direct-to-Consumer Breast Cancer Tests? First, Get the Facts

Tiffani A. DeMarco, MS, LCGC, is a licensed and certified genetic counselor and the manager of the cancer genetic counseling program at the Inova Translational Medicine Institute. She and her team of cancer genetic counselors specialize in counseling patients and family members at risk for hereditary cancers. The U.S. Food and Drug Administration (FDA) recently gave…

Read More

Looking to Technology to Improve Access & Deliver Better Healthcare

Amit Rastogi, MD, is senior vice president for strategy, growth and innovation at Inova. He serves as Inova’s principal medical innovation leader and oversees strategy development across the Inova system.   Imagine a man who is experiencing a headache. He attributes his headache to skipping his morning coffee. However, his health-tracking wearable device indicates his…

Read More

Immunotherapy: Cancer Care Gets Customized

Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics.      Tiffani A. DeMarco, MS, CGC, is a board-certified…

Read More

Prenatal Planning: Do You Need Antenatal Testing?

Alfred N. Khoury, MD, is a maternal-fetal medicine specialist at the Inova James G. Sites Antenatal Testing Center and Inova Loudoun Hospital Antenatal Testing Center. He is board-certified in maternal-fetal medicine and obstetrics and gynecology. Pregnancy is an exciting and often nerve-wracking time. But if there are concerns or complications, the James G. Sites Antenatal…

Read More

New Genetic Testing Options Could Predict Your Response to Mental Health Medications

Allison Mitchell, MS, CGS, is a laboratory genetic counselor at the Inova Genomics Laboratory, part of the Inova Translational Medicine Institute (ITMI).    We’re lucky to live in a time when there are many medications available for treating behavioral and mental health conditions such as depression, anxiety and attention-deficit/hyperactivity disorder (ADHD). However, people may respond differently to…

Read More